moxonidine has been researched along with Hypertrophy in 1 studies
moxonidine: structure given in first source
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Sayed, SS | 1 |
| Zakaria, MN | 1 |
| Abdel-Ghany, RH | 1 |
| Abdel-Rahman, AA | 1 |
1 other study available for moxonidine and Hypertrophy
| Article | Year |
|---|---|
Cystathionine-γ lyase-derived hydrogen sulfide mediates the cardiovascular protective effects of moxonidine in diabetic rats.
Topics: Adiponectin; Alkynes; Animals; Baroreflex; Blood Glucose; Body Weight; Cardiotonic Agents; Cystathio | 2016 |